adalimumab,polatuzumab vedotin
roche,abbvie
['ibd', 'pola', 'adalimumab', 'crohn']
 #ecco2023 excellent overview of regenerative medicine in #cd #fistula in addition to #mesenchymalstemcells newer approaches tried - also not game changers . we need to address this with large collaborative platform studies such as 
IBD clinician& researcher @IBDHull.Chair:Research Committee of @BritSocGastro . Chair of ECCO CLiNCOM. @NIHR (Y&H ) lead. own views ,RT🚫endorse.⚽️ @LFC fan.